|
|
|
|
|
ニューズレター
|
Abstract
These days we all suffer from information overload. To overcome this problem,
the Stem Cell News service focuses specifically on stem cell research,
delivering the information you need in a timely, flexible and convenient
format.
Much is expected from stem cell research. Controversial ethical issues, such
as harvesting and use of stem cells, are balanced by very real progress in
their research and clinical application in certain cancers, blood disorders
and tissue engineering. However, conditions as diverse as Parkinson' s disease
and diabetes are also expected to benefit.
How might stem cell research help or hinder the healthcare industry? What are
the commercial opportunities and risk? Which organisations are driving
development?
For pharmaceutical/medical company executives, researchers and commercial
managers, stem cells are taking a central role in the industry' s medium to
long-term plans. Staying in touch with the latest research and development
findings, however, is another matter. That is why this new, daily-updated
online information service is essential.
Stem Cell News provides:
- The full text of the latest news reported on stem cells, and their
research and clinical applications
- An easy-to-use interface that immediately takes you to the most recently
updated information
- An extensive archive of articles which makes the service a valuable
tracking and research tool
- A fast and effective search facility allowing you to identify information
relevant to your needs
- Daily or weekly email alerts which will ensure you know when new
information is added
- An RSS feed facility
Every day, Espicom' s researchers and editors
- Track the organisations that are undertaking novel research and shaping
the industry
- Report the latest developments in current and up coming stem cell
applications
- Monitor results from major conferences and meetings
|
 |
